These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1280403)

  • 1. Conditions associated with normal levels of prostate-specific antigen and elevation of prostatic acid phosphatase.
    Lloyd AJ; Formby MR
    Am J Clin Oncol; 1992 Dec; 15(6):487-9. PubMed ID: 1280403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostatic specific antigen (PA) in mass screening for prostate cancer].
    Ito K; Ohtake N; Hatori M; Mashimo T; Jimbo S; Tomaru Y; Makino T; Yajima H; Imai K; Yamanaka H
    Hinyokika Kiyo; 1992 Nov; 38(11):1225-9. PubMed ID: 1283053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the markers PAP-PSA in the diagnosis of cancer of the prostate].
    Petrone U; Gaspari G; Marascia G; Magnocavallo N; Petrone D; Tucci C
    Minerva Urol Nefrol; 1990; 42(2):73-5. PubMed ID: 1697431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy.
    Dutkiewicz S; Stawarz B; Lypka A; Zieliński H
    Int Urol Nephrol; 1992; 24(4):409-16. PubMed ID: 1281145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
    Csapo Z; Brand K; Walther R; Fokas K
    J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?
    Omacini S; Mione R; Barichello M; Santucci Delli Ponti U; Bolgan A; Contemori GP; Petracco S; Capitanio G; Donisi PM; Gion M
    Eur Urol; 1992; 21 Suppl 1():108-10. PubMed ID: 1385128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate adenocarcinoma using Gleason scores correlates with prostate-specific antigen and prostate acid phosphatase measurements.
    Shih WJ; Gross K; Mitchell B; Collins J; Wierzbinski B; Magoun S; Ryo UY
    J Natl Med Assoc; 1992 Dec; 84(12):1049-50. PubMed ID: 1284282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
    Buamah PK; Johnson P; Skillen AW
    Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of prostatic massage on serum levels of prostatic acid phosphatase and specific antigen].
    Sahin A; Ozen H; Balbay D; Bircan K; Koray Z; Karaagaoglu E; Remzi D
    Bull Cancer; 1992; 79(11):1097-100. PubMed ID: 1284587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.
    Siddall JK; Cooper EH; Newling DW; Robinson MR; Whelan P
    Eur Urol; 1986; 12(2):123-30. PubMed ID: 2420600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
    Morote Robles J; Ruibal Morell A; Palou Redorta J; de Torres Mateos JA; Soler Roselló A
    Eur Urol; 1988; 14(5):360-6. PubMed ID: 2458936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
    Wirth MP; Frohmüller HG
    Eur Urol; 1992; 21(4):263-8. PubMed ID: 1281102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of bone alkaline phosphatase (BAP) determined with immunoradiometric assay in metastatic prostate cancer.
    Lorente JA; Morote J
    Int J Biol Markers; 1994; 9(3):145. PubMed ID: 7530275
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate-specific antigen in management of prostatic carcinoma.
    Brawer MK; Lange PH
    Urology; 1989 May; 33(5 Suppl):11-6. PubMed ID: 2469244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal variation of prostatic acid phosphate and prostate-specific antigen in patients without prostatic malignancy.
    Simşek U; Kutlu S; Yavaşçaouğlu I; Oktay B; Ozyurt M
    Eur Urol; 1992; 21 Suppl 1():111-4. PubMed ID: 1385129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.
    Akimoto S; Inomiya H; Akakura K; Shimazaki J; Ito H
    Jpn J Clin Oncol; 1997 Aug; 27(4):258-62. PubMed ID: 9379515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum TPS, PSA, and PAP values in relapsing stage D2 adenocarcinoma of the prostate.
    Kraljić I; Kovacić K; Tarle M
    Urol Res; 1994; 22(5):329-32. PubMed ID: 7533445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
    Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC
    Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.